Search

Search results

5012 results found

Production, characterization, and use of monoclonal antibodies directed against human blood platelet thrombospondin: immunologic comparison with human endothelial and fibroblast thrombospondins.

Clezardin, P, N R Hunter, J Lawler, J Dawes, and J L McGregor. 1987. “Production, Characterization, and Use of Monoclonal Antibodies Directed Against Human Blood Platelet Thrombospondin: Immunologic Comparison With Human Endothelial and Fibroblast Thrombospondins.”. Seminars in Thrombosis and Hemostasis 13 (3): 261-75.

Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer.

Matuszewska, Kathy, Simone Ten Kortenaar, Madison Pereira, Lisa A Santry, Duncan Petrik, Kin-Ming Lo, Byram W Bridle, Sarah K Wootton, Jack Lawler, and Jim Petrik. 2022. “Addition of an Fc-IgG Induces Receptor Clustering and Increases the in Vitro Efficacy and in Vivo Anti-Tumor Properties of the Thrombospondin-1 Type I Repeats (3TSR) in a Mouse Model of Advanced Stage Ovarian Cancer.”. Gynecologic Oncology 164 (1): 154-69.

AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma.

Yu, Darrick L, Ashley A Stegelmeier, Natalie Chow, Amira D Rghei, Kathy Matuszewska, Jack Lawler, Byram W Bridle, James J Petrik, and Sarah K Wootton. 2020. “AAV-Mediated Expression of 3TSR Inhibits Tumor and Metastatic Lesion Development and Extends Survival in a Murine Model of Epithelial Ovarian Carcinoma.”. Cancer Gene Therapy 27 (5): 356-67.